Picture of Dianthus Therapeutics logo

DNTH — Dianthus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Dianthus Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

* Dianthus Therapeutics Inc  DNTH.OQ  reported a quarterly
adjusted loss of 72 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $-3.78.  The mean expectation of
ten analysts for the quarter was for a loss of 59 cents per
share. Wall Street expected results to range from -73 cents
to -50 cents per share.
    * Revenue rose 135.1% to $2.17 million from a year ago;
analysts
expected $648.50 thousand. 
    * Dianthus Therapeutics Inc's reported EPS for the quarter
was a
loss of 74 cents​.
    * The company reported a quarterly loss of $25.17 million.
    * Dianthus Therapeutics Inc shares had risen by 7.4% this
quarter and gained 182.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 11 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Dianthus
Therapeutics Inc is 46.50 
This summary was machine generated from LSEG data November 8 at
04:59 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.59          -0.72          Missed
 Jun. 30 2024      -0.55          -0.51          Beat
 Mar. 31 2024      -0.44          -0.54          Missed
 Dec. 31 2023      -1.01          -0.71          Beat

Recent news on Dianthus Therapeutics

See all news